xxvPersonalizing New Therapies for CF .................................................... 548
Gene Therapy and Pharmacogenomic Approach to CF ........................ 548
References ................................................................................................. 54817 Personalized Approaches to Immune Disorders .................................. 551
Introduction ............................................................................................... 551
Personalized Approaches in Immunology ................................................ 552
Pharmacogenetics and Pharmacogenomics of Immunosuppression ......... 552
Personalized Management of Patients with Lupus Erythematosus .......... 553
Personalized Therapy of Rheumatoid Arthritis ......................................... 554
Genetics and Epigenetic Aspects of Rheumatoid Arthritis ................... 554
Variations in the Effectiveness of Various Treatments of RA ............... 555
Biomarkers for Personalizing Therapy of Rheumatoid Arthritis .......... 556
DIATSTAT™ Anti-cyclic Citrullinated Peptides
in Rheumatoid Arthritis......................................................................... 557
Personalization of COX-2 Inhibitor Therapy........................................ 557
Personalization of Infl iximab Therapy .................................................. 557
Personalized Therapy of RA Guided by Anti-citrullinated
Protein Antibodies ................................................................................. 558
Personalized Approaches to Improve Organ Transplantation ................... 558
Personalization of Kidney Transplantation ........................................... 558
Personalization of Cardiac Transplantation .......................................... 559
Prediction of Rejection for Personalizing Anti-rejection
Treatment .............................................................................................. 560
Personalized Immunosuppressant Therapy
in Organ Transplants ............................................................................. 560
Role of Immunological Biomarkers in Monitoring
Grafted Patients ..................................................................................... 561
Improved Matching of Blood Transfusion ................................................ 563
References ................................................................................................. 563
18 Personalized Approaches to Miscellaneous Problems
in Healthcare ........................................................................................... 565
Personalized Management of Diabetes ..................................................... 565
Personalized Management of Gastrointestinal Disorders ......................... 566
Infl ammatory Bowel Disease ................................................................ 566
Personalized Management of Lactose Intolerance ............................... 568
Personalized Geriatrics ............................................................................. 568
Chronological vs Biological Age .......................................................... 568
Pharmacogenetics and Adverse Drug Reactions ................................... 569
Personalized Management of Skin Disorders ........................................... 569
Genetic Testing for Personalized Skin Care ......................................... 569
Management of Hair Loss Based on Genetic Testing ........................... 570
Personalized Preventive Medicine ............................................................ 570
Female Sexual Dysfunction ...................................................................... 571
Hormone Replacement Therapy in Women .......................................... 571
Contents